Arthritis Therapy Brattleboro VT

Local resource for arthritis therapy in Brattleboro. Includes detailed information on local businesses that provide access to arthritis pain relief, arthritis medication, arthritis natural treatments, rheumatoid arthritis treatments, physical therapy, and occupational therapy, as well as advice and content on arthritis surgery.

Dr.David Patek
(603) 924-7191
21 Belmont Avenue
Brattleboro, VT
Gender
M
Education
Medical School: Columbia Univ Coll Of Physicians And Surgeons
Year of Graduation: 1962
Speciality
Rheumatologist
General Information
Hospital: Monadnock Community Hospital
Accepting New Patients: Yes
RateMD Rating
2.0, out of 5 based on 1, reviews.

Data Provided By:
John G Schlegelmilch
(603) 354-5450
590 Court St
Keene, NH
Specialty
Internal Medicine, Rheumatology

Data Provided By:
Todd David Daugherty
(603) 354-5400
590 Court St
Keene, NH
Specialty
Rheumatology

Data Provided By:
Richard A Brown
(413) 774-6301
329 Conway St
Greenfield, MA
Specialty
Rheumatology

Data Provided By:
Thomas W Martenis, MD
(802) 658-9255
7 Chelmsford Grn
South Burlington, VT
Specialties
Internal Medicine, Rheumatology
Gender
Male
Education
Medical School: Univ Of Pa Sch Of Med, Philadelphia Pa 1
Graduation Year: 1960

Data Provided By:
David Jackson Patek
(802) 257-8363
21 Belmont Ave
Brattleboro, VT
Specialty
Internal Medicine, Rheumatology

Data Provided By:
Nicholas Henry Bartenhagen
(603) 354-6570
590 Court St
Keene, NH
Specialty
Rheumatology

Data Provided By:
John Schlegelmilch, MD
(603) 354-5400
580 Court St
Keene, NH
Specialties
Internal Medicine, Rheumatology
Gender
Male
Education
Medical School: Suny-Hlth Sci Ctr At Brooklyn, Coll Of Med, Brooklyn Ny 11203
Graduation Year: 1975

Data Provided By:
Christine Ann Jones, MD
(605) 341-5272
1 S Prospect St
Burlington, VT
Specialties
Internal Medicine, Rheumatology
Gender
Female
Education
Medical School: Univ Of Mn Med Sch-Minneapolis, Minneapolis Mn 55455
Graduation Year: 1995

Data Provided By:
Kevin D Kerin
(802) 295-9363
215 N Main St
White River Junction, VT
Specialty
Internal Medicine, Rheumatology

Data Provided By:
Data Provided By:

New, Targeted Therapies for Arthritis

There are many different types of rheumatological diseases. A rheumatological disease is an inflammatory arthritis that affects the entire body as a whole. Rheumatoid arthritis (RA) is the most common rheumatologic disease. Certain types of rheumatoid arthritis seem to target specific joints.

When a rheumatological disease affects the spine, the resulting conditon is called a spondyloarthropathy. The term is made up of Greek words: Spondylo means vertebra, arthro means joint and pathos means disease. When other more peripheral joints are affected (such as in the arms and legs), the rheumatologic arthritis is referred to as an spondyloarthritide.

In this article, Dr. Philip J. Mease from the Division of Rheumatology, University School of Medicine in Seattle, Washington gives us an update on two of the more common spondyloarthropathies: psoriatic arthritis (PsA) and ankylosing spondylitis (AS). Psoriatric arthritis affects the peripheral joints. Ankylosing spondylitis affects the spine.

New findings in the field have brought these conditions and their treatment to our attention. The first major breakthrough in understanding and treating these diseases is in the area of pathophysiology. Pathophysiology tells us what went wrong at the cellular level to cause these problems.

Researchers are identifying specific differences between rheumatoid arthritis and spondyloarthropathies. Their work in the field of osteoimmunology is helping determine what's going on between the bone cells (osteo) and the immune system. This knowledge has led to more refined development of specific drug treatments for these two types of arthritis. That's good news for anyone suffering from any kind of rheumatologic disease.

For example, MRIs of patients with spondyloarthropathies show bone edema before any actual bone damage occurs in the joints. At the same time, they have found nests of lymphocytes (white blood cells), bone cells, and blood in the bone marrow (inside bones) of patients with ankylosing spondylitis. Though the exact meaining of these findings are unknown, they point in a direction to help drug manufacturers develop medications that could stop this process.

Measuring the effect of therapy on disease activity is one way to assess new treatments. Studies look at before and after outcomes of therapy on affected joints, skin, pain, function, fatigue, and quality of life. The therapeutic effects of treatment on disease activity can be difficult to measure -- especially when those changes occur at the cellular level. MRIs and X-rays may be helpful.

Patient-reported outcomes using various surveys can help track patient perceived changes, too. Some of these tools include the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Bath Ankylosing Spondylitis Function Index (BASFI), and the Ankylosing Spondylitis Quality of Life (ASQoL) questionnaire.

Standard treatment of mild spondyloarthropathies start...

Click here to read the rest of this article from eOrthopod.com